Paula Cannon, PhD, Distinguished Professor of Molecular Microbiology & Immunology with the Keck School of Medicine of USC, has become the president of the American Society of Gene and Cell Therapy (ASGCT), the world’s largest organization devoted to developing next-generation therapies that address the underlying causes of disease.

Established in 1996, the ASGCT has more than 6,000 members worldwide, including scientists, physicians, patient advocates, policymakers and biotechnology and pharmaceutical professionals.

Cannon, who is also associate director of Cross School Programs for the MESH Academy, special advisor to the provost, and in charge of the Cannon Lab at USC, specializes in studying viruses, stem cells and gene therapies with a goal of defeating HIV/AIDS.

To read the full story, click here.